Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided cautious first-quarter guidance.
- Quest said it continues to expect full-year 2025 net revenue to be in the range of $10.70 billion to $10.85 billion
- The guidance represents an 8.4% to $9.9% increase in full-year net revenue
- The company reaffirmed its earnings per share guidance for FY25, on a reported basis, in the $8.34-$8.59 range
- Adjusted earnings per share are expected to be between $9.55 and $9.80 in the fiscal year, which is in line with the previous guidance
- The management continues to expect cash provided by operations to be approximately $1.45 billion in FY25, and capital expenditure to be $500 million
- For the first quarter of 2025, the company expects the worse-than-anticipated weather to create a headwind to revenue of around $25 million, and to EPS of about $0.10
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Kroger’s (KR) Q3 2025 earnings results
The Kroger Co. (NYSE: KR) reported its third quarter 2025 earnings results today. Total company sales rose to $33.9 billion from $33.6 billion in the same period last year. Identical
Dollar General (DG) Q3 2025 Earnings: Key financials and quarterly highlights
Dollar General Corporation (NYSE: DG) reported its third quarter 2025 earnings results today. Net sales increased 4.6% year-over-year to $10.65 billion. Same-store sales increased 2.5%. Net income was $282.7 million, or
HRL Earnings: All you need to know about Hormel Foods’ Q4 2025 earnings results
Hormel Foods Corporation (NYSE: HRL) reported its fourth quarter 2025 earnings results today. Net sales increased 1.5% year-over-year to $3.18 billion. Organic sales were up 2%. Net loss attributable to Hormel
